UNIVERSITY OF TENNESSEE MEDICAL CENT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $15.5M
- Transactions
- 2,561
- Companies
- 40
- Average per transaction
- $6,047
Who reported the payments
| Merck | $3,009,173 |
| Regeneron | $1,410,769 |
| Siemens Medical Solutions USA, Inc. | $1,391,057 |
| Novartis | $866,813 |
| Seagen Inc. | $779,359 |
| Amgen | $736,717 |
| GE HealthCare | $701,139 |
| Eli Lilly | $503,458 |
| Astrazeneca UK Limited | $382,882 |
| Janssen Research & Development, LLC | $345,911 |
| Pfizer | $328,442 |
| E.r. Squibb & Sons, L.L.C. | $306,391 |
| Intuitive Surgical | $295,743 |
| Vertex | $289,597 |
| Centinel Spine, LLC | $284,320 |
| Genentech, Inc. | $270,751 |
| Biontech SE | $225,210 |
| CSL Behring | $220,383 |
| AstraZeneca | $182,596 |
| Kls-martin L.p. | $181,250 |
| Genmab A/s | $162,403 |
| Bristol Myers Squibb | $131,942 |
| Cleerly, Inc. | $128,529 |
| Transmedics, Inc. | $116,500 |
| Johnson & Johnson | $114,018 |
| Ascendis Pharma Endocrinology Inc | $111,930 |
| Eisai Inc. | $108,838 |
| GSK | $105,808 |
| Beigene, Ltd. | $92,390 |
| Inari Medical, Inc. | $84,392 |
| Medical Device Business Services, Inc. | $73,008 |
| Medline Industries LP | $66,254 |
| Dr.reddy's Laboratories,inc. | $62,313 |
| Penumbra, Inc. | $61,225 |
| Tesaro, Inc. | $61,025 |
| KARL Storz Endoscopy-america | $61,022 |
| Corcept Therapeutics | $54,890 |
| Iovance Biotherapeutics, Inc. | $53,319 |
| Stryker | $52,538 |
| Trillium Therapeutics USA, LLC | $49,075 |